Evidence map›Paper›PMID 30871292›Full record

ArticleKnee surgery & related research2019

Intra-articular Recombinant Human Growth Hormone Injection Compared with Hyaluronic Acid and Placebo for an Osteoarthritis Model of New Zealand Rabbits.

Andri Maruli Tua Lubis, Erick Wonggokusuma, Aldo Fransiskus Marsetio

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Knee surgery & related research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07036003 (Recombinant Human Growth Hormone), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07036003 phase1 / phase2active not recruitingnot on this mapstarted 2025, after this paper: background citation

Recombinant Human Growth Hormone (rHGH) for Knee Osteoarthritis (KORR): a Pilot, Randomized Placebo-controlled Trial

TypeinterventionalSponsorDr. David WassersteinRan2025 to 2029Enrolled34ConditionsKnee Osteoarthritis (Knee OA), Knee Osteoarthritis (OA)ArmsSomatropin (recombinant human growth hormone), bacteriostatic saline placebo
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Animal Models of Osteoarthritis: Updated Models and Outcome Measures 2016-2023.Regenerative engineering and translational medicine · 2024
    Article
  2. Article
  3. Review
  4. Bone Marrow Aspirate Matrix: A Convenient Ally in Regenerative Medicine.International journal of molecular sciences · 2021
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Andri Maruli Tua LubisDepartment of Orthopaedic and Traumatology, Faculty of Medicine, Universitas Indonesia and Department of Orthopaedic and Traumatology, Cipto Mangunkusumo Hospital, Jakarta.
Erick WonggokusumaDepartment of General Orthopaedic, Siloam Hospital Kebon Jeruk, Jakarta, Indonesia.
Aldo Fransiskus MarsetioDepartment of Orthopaedic and Traumatology, Faculty of Medicine, Universitas Indonesia and Department of Orthopaedic and Traumatology, Cipto Mangunkusumo Hospital, Jakarta.
Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo · IDUniversity of Indonesia · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeUp to now, there is no feasible solution for stopping or reversing the degenerative process of osteoarthritis (OA). Our study evaluated the effect of intra-articular injection of growth hormone (GH) in OA-induced rabbit knees compared to hyaluronic acid (HA) and placebo. MATERIALS AND

methodsA total of 21 male, skeletally mature, New Zealand rabbits received an intra-articular type II collagenase injection for OA induction. Two weeks later, the rabbits were randomized into three groups based on the weekly intra-articular injection to be received: GH, HA, and saline. Injections were done for three consecutive weeks. Evaluation was done at 8 weeks after treatment, clinically using the lameness period, macroscopically using the Yoshimi score and microscopically using the Mankin score.

resultsThe shortest period of lameness was found in the GH group (15.9±2.12 days), compared to the HA group (19.4±1.72 days) and placebo group (25.0±2.94 days). There was a statistically significant difference in macroscopic scoring between groups (p=0.001) in favor of the GH group. There was also significant difference in the microscopic score between groups (p=0.001) also in favor of the GH group.

conclusionsIntra-articular injection of GH showed better clinical, macroscopic and microscopic results as compared to HA and placebo.

Indexed as

Growth hormoneHyaluronic acidKneeOsteoarthritis

Identifiers

PMID30871292
PMCPMC6425894
OpenAlexW2921142508

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.